SAFE Notes Explained: Everything Founders Need to Know

What is a SAFE?

A Simple Agreement for Future Equity (SAFE) is Y Combinator's answer to convertible notes. Introduced in 2013, SAFEs have become the default instrument for pre-seed and seed fundraising.

The pitch: No interest rate, no maturity date, no debt on your balance sheet. Just a simple promise: "Give us money now, we'll give you equity later when we raise a priced round."

SAFEs sound founder-friendly, but they can cause massive, unexpected dilution if you don't understand the conversion mechanics. I've seen founders raise $2M on SAFEs thinking they gave up 15%, only to discover post-Series A they gave up 30%.

How SAFEs Work: The Mechanics

A SAFE is a contract where an investor gives you cash today in exchange for the right to receive equity in the future, specifically when a "liquidity event" occurs (usually your next priced equity round).

Key trigger events:

• Equity Financing: You raise a priced round (typically $1M+ from institutional investors). SAFEs convert to the same stock the new investors buy, but at a better price.
• Liquidity Event: You sell the company or IPO. SAFE holders get cash or stock based on their conversion terms.
• Dissolution: Company shuts down. SAFE holders get paid back before common shareholders (after debt and preferred stock).

The complexity lies in how much stock SAFE holders receive when they convert. This depends on two key terms: the valuation cap and the discount.

Valuation Cap: Your Maximum Valuation

The valuation cap is the maximum effective valuation at which your SAFE converts, regardless of your Series A price.

Example: You raise $500K on a SAFE with a $5M cap. Your Series A happens at a $20M pre-money valuation. The SAFE investors don't convert at $20M—they convert at $5M (the cap), giving them 4x better pricing than Series A investors.

Math:

• SAFE investment: $500K
• Valuation cap: $5M
• Conversion ownership: $500K / $5M = 10%
• Series A investors at $20M pre-money: pay 4x more per share

This is why investors love high caps and founders want low caps. The cap determines how much of your company you're actually selling, and you won't know the final number until your Series A pricing is set.

Discount: The Alternative Benefit

The discount gives SAFE investors a percentage discount on the Series A price per share, typically 15-20%.

Example: You raise $500K on a SAFE with a 20% discount. Your Series A happens at $20M pre-money, $1.00 per share. SAFE investors convert at $0.80 per share (20% discount), getting 25% more shares for their money.

The key rule: SAFEs convert using whichever is BETTER for the investor—the cap or the discount. Not both. One or the other.

Cap vs. Discount Decision Tree:

• If Series A valuation > Cap: Cap wins (better for investor)
• If Series A valuation < Cap: Discount wins (if it provides better pricing)

In practice, when you raise at a significant markup (3x+ your SAFE cap), the cap always controls. The discount only matters if your Series A valuation is close to your SAFE cap.

Post-Money vs. Pre-Money SAFEs

In 2018, Y Combinator updated the SAFE from "pre-money" to "post-money" to address a major issue: nobody knew how much they were actually selling.

Pre-Money SAFE (pre-2018, still used by some):

The cap represents a pre-money valuation, and the SAFE holders' ownership percentage depends on how many other SAFEs you raise. If you raise multiple SAFEs, each one dilutes the previous ones, creating a complex cascade.

Post-Money SAFE (current standard):

The cap represents a post-money valuation, and the SAFE explicitly states what percentage of the "SAFE Post-Money Valuation" the investor receives. This percentage is fixed—multiple SAFEs don't dilute each other.

Example:

• You raise $500K on a post-money SAFE with a $5M cap
• Investor gets: $500K / $5M = 10% of the post-money SAFE valuation
• If you raise another $300K on a post-money SAFE at a $6M cap, that investor gets: $300K / $6M = 5%
• Total SAFE dilution: exactly 15% (10% + 5%)

With pre-money SAFEs, the math was uglier, and founders often didn't know their total dilution until conversion. Always use post-money SAFEs.

MFN (Most Favored Nation) Clause

Some SAFEs include an MFN clause: if you issue later SAFEs with better terms (lower cap, higher discount), earlier SAFE holders automatically get those better terms.

This sounds minor but can be catastrophic. If you raise at a $5M cap and later need a bridge at a $3M cap (maybe traction slowed), your original investors now convert at $3M too, doubling their dilution impact.

Advice: Avoid MFN clauses unless you have no other option. They create asymmetric risk—investors get upside from your later success via the cap, AND downside protection if terms worsen.

Common SAFE Pitfalls

Pitfall #1: Death by a Thousand SAFEs

Raising $50K here, $100K there, $200K from angels. Before you know it, you've raised $1.5M on SAFEs at a $6M cap = 25% dilution before your Series A even starts. Then Series A takes another 25%. You're sub-50% ownership before Series B.

Solution: Set a hard cap on total SAFE fundraising (e.g., $1M max) and track dilution in real-time.

Pitfall #2: Mismatched Cap and Series A Valuation

You raise $1M on SAFEs at a $10M cap, expecting a $30M Series A. But traction is slower than expected. You raise Series A at $15M pre-money. Your SAFEs convert at $10M, taking 10% ($1M / $10M). Combined with Series A dilution, you're shocked by total dilution.

Solution: Model scenarios where your Series A comes in below, at, and above your SAFE cap. Understand dilution in all cases before you set the cap.

Pitfall #3: Ignoring Pro-Rata Rights

Some SAFEs include pro-rata rights—the investor can invest more in your Series A to maintain their ownership percentage. This isn't inherently bad, but it reduces the amount of "fresh" money you can raise from new investors.

Solution: Understand who has pro-rata rights and estimate how much they'll exercise. If you want to raise $5M in Series A but $1M is spoken for via pro-rata, you're only bringing in $4M of new capital.

Pitfall #4: Not Converting Before Acquisition

Someone offers to acquire your company for $15M before you raise a Series A. Your SAFEs haven't converted yet. Depending on the SAFE terms, investors might get their money back plus a small return, while you thought they'd get 20% of the proceeds. This misalignment can kill deals.

Solution: Review the "Liquidity Event" section of your SAFE carefully. Understand what happens in an acquisition before a conversion. Consider converting SAFEs to equity before entering acquisition talks.

When to Use SAFEs vs. Priced Rounds

Use SAFEs when:

• Raising pre-seed or seed from angels and small funds
• Need speed (SAFEs close in days vs. weeks for priced rounds)
• Raising smaller amounts ($50K-$2M)
• Want to avoid setting a valuation before you have strong traction

Use priced rounds when:

• Raising larger amounts ($3M+)
• Raising from institutional VCs who require preferred stock
• Have strong traction and can command a clear, defensible valuation
• Want certainty on dilution (priced rounds tell you exactly what you're selling)

Conclusion

SAFEs are powerful tools when used correctly: fast, simple, and flexible. But they're not "free money with delayed dilution." Every SAFE is a future equity sale at terms you won't fully understand until your Series A.

Track every SAFE meticulously. Model conversion scenarios at different Series A valuations. Set hard caps on total SAFE fundraising. And always, always use post-money SAFEs.

The founders who master SAFEs are the ones who treat them with the respect they deserve—not as footnotes, but as significant equity sales that shape their cap table for life.